top of page
Item List
Businesswire
Carlsmed Raises $52.5M in Series C Financing to Advance Personalized Spine Surgery
Carlsmed, an AI-enabled personalized surgery Medtech company, announced today a $52.5M Series C funding round co-led by B Capital and U.S. Venture Partners. These proceeds will be used to accelerate the commercialization of the aprevo® personalized spine surgery platform for lumbar fusion procedures and the development of aprevo® for cervical fusions, which will launch in 2025.
Recent Posts
bottom of page